13-264
Showing 1 - 25 of 4,582
Bioequivalence Trial in Erfurt (RID-TDS 13.3 mg/24 h, Exelon® 13.3 mg/24 h)
Recruiting
- Bioequivalence
- RID-TDS 13.3 mg/24 h
- Exelon® 13.3 mg/24 h
-
Erfurt, Thüringen, GermanySocraTec R&D GmbH, Clinical Pharmacology Unit
May 2, 2023
Duchenne Muscular Dystrophy Trial (delandistrogene moxeparvovec)
Not yet recruiting
- Duchenne Muscular Dystrophy
- delandistrogene moxeparvovec
- (no location specified)
Nov 8, 2023
Advanced Solid Tumor Trial in Nanchang, Jinan, Shanghai (RGT-264 phosphate tablets)
Recruiting
- Advanced Solid Tumor
- RGT-264 phosphate tablets
-
Nanchang, Jiangxi, China
- +2 more
Feb 28, 2023
Healthy Trial in Austin ([phenyl-14C]ARV-471, [oxoisoindolin-14C]ARV-471)
Recruiting
- Healthy
-
Austin, TexasPPD Phase I Clinic
Jun 29, 2023
Localized Stage I-III Esophageal Cancer, Gastroesophageal Junction Cancer Trial in United States (nutritional and functional
Completed
- Localized Stage I-III Esophageal Cancer
- Gastroesophageal Junction Cancer
- nutritional and functional assessments
-
Basking Ridge, New Jersey
- +6 more
Mar 7, 2022
Behaviors, Health Trial in Hong Kong (HIVST-Chatbot (HIV self-testing services with counseling provided by a Chatbot), HIVST-OIC
Not yet recruiting
- Behaviors, Health
- HIVST-Chatbot (HIV self-testing services with counseling provided by a Chatbot)
- HIVST-OIC (HIV self-testing services with counseling provided by administrators)
-
Hong Kong, Hong KongCentre for Health Behaviours Research, the Chinese University of
Mar 31, 2023
Mild to Severe Hypertension Trial (MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 6 weeks,
Completed
- Mild to Severe Hypertension
- MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 6 weeks
- losartan / Duration of Treatment: 6 weeks
- (no location specified)
Feb 7, 2022
Suicide, Attempted, Suicide and Depression, Suicide Threat Trial in Dallas (Ketamine Hydrochloride, Midazolam Hydrochloride)
Recruiting
- Suicide, Attempted
- +2 more
- Ketamine Hydrochloride
- Midazolam Hydrochloride
-
Dallas, TexasUT Southwestern Medical Center
Nov 3, 2022
Emotional Regulation Trial in Cluj-Napoca (REThink Game, MoodWheel, PsyPills)
Recruiting
- Emotional Regulation
- REThink Game
- +2 more
-
Cluj-Napoca, RomaniaBabes-Bolyai University
Oct 18, 2023
Gastric Cancer, Gastric Adenocarcinoma, Peritoneal Carcinomatosis Trial in Montréal, Quebec City (Indocyanine green)
Recruiting
- Gastric Cancer
- +3 more
- Indocyanine green
-
Montréal, Quebec, Canada
- +1 more
Jan 8, 2023
Blood Donation Trial (supplementation with low dose elemental iron)
Not yet recruiting
- Blood Donation
- supplementation with low dose elemental iron
- (no location specified)
Oct 23, 2023
Wrinkle Trial in Chicago (Tixel 2)
Recruiting
- Wrinkle
- Tixel 2
-
Chicago, IllinoisPhysicians Laser & Dermatology Institute, LLC
Mar 7, 2022
Chronic Myelogenous Leukemia Trial in Worldwide (Nilotinib followed by treatment-free)
Active, not recruiting
- Chronic Myelogenous Leukemia
- Nilotinib followed by treatment-free
-
Fort Myers, Florida
- +113 more
Apr 25, 2022
Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Pneumococcal 13-valent conjugate vaccine (PCV-13))
Completed
- Rheumatoid Arthritis
- Upadacitinib
- Pneumococcal 13-valent conjugate vaccine (PCV-13)
-
Huntsville, Alabama
- +123 more
Jun 15, 2022
Cluster C Personality Disorder (Diagnosis), Mother-Child Relations Trial (Group schematherapy)
Not yet recruiting
- Cluster C Personality Disorder (Diagnosis)
- Mother-Child Relations
- Group schematherapy
- (no location specified)
Oct 21, 2023
Exosome for Early Diagnosis of Bipolar Affective Disorder
Not yet recruiting
- Bipolar Affective Disorder
- Major Depressive Disorder
-
Tianjin, ChinaTianjin Anding Hospital
Jun 13, 2023
Rheumatoid Arthritis Trial in Worldwide (SAR153191 (REGN88))
Completed
- Rheumatoid Arthritis
- SAR153191 (REGN88)
-
Anniston, Alabama
- +334 more
Mar 21, 2022
Heart Arrest Trial in Denmark (Vasopressin, Arginine, Methylprednisolone, NaCl)
Completed
- Heart Arrest
- Vasopressin, Arginine
- +2 more
-
Aalborg, Denmark
- +9 more
Feb 17, 2022
Olfactory Cleft Stenosis and Obstruction on Paranasal Sinus CT
Recruiting
- Olfactory Impairment
-
Nancy, France
- +1 more
Oct 8, 2023
Autoimmune Inner Ear Disease Trial in New Hyde Park (Anakinra 100Mg/0.67Ml Inj Syringe (Period 1), Placebo injection (Period 1),
Recruiting
- Autoimmune Inner Ear Disease
- Anakinra 100Mg/0.67Ml Inj Syringe (Period 1)
- +3 more
-
New Hyde Park, New YorkNorthwell Health, Hearing& Speech Center
Oct 18, 2022